Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-051043

Director acquired 6,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
EASTHAM KARIN Director 2019-09-25 Grant or award +6,500 15,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
EASTHAM KARIN Director 2019-09-25 Grant or award · Stock Option +13,000 13,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…